2) Biological Warfare Defense Therapeutics - Enhanced Biodefense (ENBD)
Abstract
This effort focuses on Drug Repurposing; Micro physiological Systems; Small Molecule Libraries; and Science & Technology Host Response Studies. Activities include expediting a response to emerging threats by assessing broad-spectrum efficacy of approved drugs against biological threats (i.e., drug repurposing), advancing repurposed drugs against biological threats for U.S. Food & Drug Administration (FDA) approval; developing tools (e.g., small molecule libraries) to expedite discovery and development of therapeutic candidates in response to an emerging threat; and, identifying and developing technologies that target host response to disease caused by biological threats.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2024
- Source ID
- 3985edc0b7d30e664eb21e7fd30caa53